International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020

Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Matheeussen, Veerle, Corman, Victor M, Donoso Mantke, Oliver, McCulloch, Elaine, Lammens, Christine, Goossens, Herman, Niemeyer, Daniela, Wallace, Paul S, Klapper, Paul, Niesters, Hubert GM, Drosten, Christian, Ieven, Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2020
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364759/
https://www.ncbi.nlm.nih.gov/pubmed/32672149
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.27.2001223
_version_ 1783559894630137856
author Matheeussen, Veerle
Corman, Victor M
Donoso Mantke, Oliver
McCulloch, Elaine
Lammens, Christine
Goossens, Herman
Niemeyer, Daniela
Wallace, Paul S
Klapper, Paul
Niesters, Hubert GM
Drosten, Christian
Ieven, Margareta
author_facet Matheeussen, Veerle
Corman, Victor M
Donoso Mantke, Oliver
McCulloch, Elaine
Lammens, Christine
Goossens, Herman
Niemeyer, Daniela
Wallace, Paul S
Klapper, Paul
Niesters, Hubert GM
Drosten, Christian
Ieven, Margareta
author_sort Matheeussen, Veerle
collection PubMed
description Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories.
format Online
Article
Text
id pubmed-7364759
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-73647592020-07-17 International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020 Matheeussen, Veerle Corman, Victor M Donoso Mantke, Oliver McCulloch, Elaine Lammens, Christine Goossens, Herman Niemeyer, Daniela Wallace, Paul S Klapper, Paul Niesters, Hubert GM Drosten, Christian Ieven, Margareta Euro Surveill Rapid Communication Laboratory preparedness with quality-assured diagnostic assays is essential for controlling the current coronavirus disease (COVID-19) outbreak. We conducted an external quality assessment study with inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) samples to support clinical laboratories with a proficiency testing option for molecular assays. To analyse SARS-CoV-2 testing performance, we used an online questionnaire developed for the European Union project RECOVER to assess molecular testing capacities in clinical diagnostic laboratories. European Centre for Disease Prevention and Control (ECDC) 2020-07-09 /pmc/articles/PMC7364759/ /pubmed/32672149 http://dx.doi.org/10.2807/1560-7917.ES.2020.25.27.2001223 Text en This article is copyright of the authors or their affiliated institutions, 2020. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Rapid Communication
Matheeussen, Veerle
Corman, Victor M
Donoso Mantke, Oliver
McCulloch, Elaine
Lammens, Christine
Goossens, Herman
Niemeyer, Daniela
Wallace, Paul S
Klapper, Paul
Niesters, Hubert GM
Drosten, Christian
Ieven, Margareta
International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title_full International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title_fullStr International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title_full_unstemmed International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title_short International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020
title_sort international external quality assessment for sars-cov-2 molecular detection and survey on clinical laboratory preparedness during the covid-19 pandemic, april/may 2020
topic Rapid Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364759/
https://www.ncbi.nlm.nih.gov/pubmed/32672149
http://dx.doi.org/10.2807/1560-7917.ES.2020.25.27.2001223
work_keys_str_mv AT matheeussenveerle internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT cormanvictorm internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT donosomantkeoliver internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT mccullochelaine internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT lammenschristine internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT goossensherman internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT niemeyerdaniela internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT wallacepauls internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT klapperpaul internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT niestershubertgm internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT drostenchristian internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT ievenmargareta internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020
AT internationalexternalqualityassessmentforsarscov2moleculardetectionandsurveyonclinicallaboratorypreparednessduringthecovid19pandemicaprilmay2020

Ejemplares similares